CAPTURA BIOPHARMA
Captura Biopharma is an biotechnology company engaged in the development and commercialization of heavy metal chelators useful in the treatment of internal radionuclide contamination and heavy metal poisoning. Its lead chelation candidate, C2E2, will be the world's first oral treatment indicated for internal radiation contamination and has been proven in efficacy studies to target select heavy metals, notably americium, plutonium, and lead. Heavy metal contamination, including exposure to transuranic elements, is on the rise.
CAPTURA BIOPHARMA
Social Links:
Industry:
Biopharma Biotechnology Life Science
Founded:
2019-01-01
Address:
Little Rock, Arkansas, United States
Country:
United States
Website Url:
http://www.capturabiopharma.com
Total Employee:
1+
Status:
Active
Contact:
501-516-3905
Email Addresses:
[email protected]
Total Funding:
50 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Tag Manager WordPress Google Universal Analytics Font Awesome Global Site Tag Nginx
Similar Organizations
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Demetrix
Demetrix is a biotechnology company dedicated to researching and producing bioactive ingredients.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Pilot Biotechnology
Pilot Biotechnology is an industrial biotechnology company engaged in the development, production, and sales of health care products.
Current Employees Featured
Founder
Investors List
The Global Emerging Markets Group
The Global Emerging Markets Group investment in Venture Round - Captura Biopharma
Official Site Inspections
http://www.capturabiopharma.com
- Host name: 255.209.73.34.bc.googleusercontent.com
- IP address: 34.73.209.255
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Captura Biopharma"
About - Captura Biopharma
Captura Biopharma was founded by Michael Geranen and Anthony Soscia based on research performed at the University of North Carolina. Captura is located in Little Rock, AR and it’s …See details»
The Captura Team - Captura Biopharma
Dr. Gary Barnette Ph.D., Regulatory. Dr. Barnette was Sr. Vice President of Scientific and Regulatory Affairs at Camargo Pharmaceutical Services, LLC from 2012 to August 2018 and had responsibility of the oversight and development …See details»
Captura Biopharma Company Profile | Management and …
[email protected]: Captura Biopharma Top Competitors. Company Employees Revenue Top technologies; Velesco Pharmaceutical Services Inc. 15: $6.3 M: Yeahhh Baby! …See details»
Captura Biopharma - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 501-516-3905 Captura Biopharma is an biotechnology company engaged in the development and commercialization …See details»
Captura Biopharma - The Org
Captura Biopharma is developing an oral solution that can immediately be administered to eliminate harmful radioactive material from the body.See details»
Captura Biopharma, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Captura Biopharma, Inc. of Little Rock, AR. Get the latest business insights from Dun & Bradstreet.See details»
Captura Biopharma - Company Profile & Staff Directory
We are a group of Pharmaceutical Industry Executives, Military Vets, and Civic Volunteers dedicated to averting Public Health crisis related to Lead Poising, Radiation Poisoning, and …See details»
Captura Biopharma - PitchBook
Captura Biopharma General Information Description. Operator of a biotechnology company engaged in the development of IV chelation drugs. The company offers drugs for the treatment …See details»
Captura Biopharma - Crustdata Company Profile, Funding and …
Captura Biopharma is an biotechnology company engaged in the development and commercialization of heavy metal chelators useful in the treatment of internal radionuclide …See details»
Captura Biopharma - Company Profile - Tracxn
Nov 5, 2024 Captura Biopharma - Developer of therapeutic to eliminate harmful radioactive material from the body. Acquired by OceanTech Acquisitions. Raised funding over 1 round …See details»
Captura Biopharma - VentureRadar
Similar Companies: Sun BioPharma USA Private Sun BioPharma is developing small-molecule pharmaceuticals consisting of novel polyamine analogues and metal chelators, and MGI …See details»
Contact Us - Captura Biopharma
Looking to Get Involved in this Venture? If you would like to receive C2E2 technical docs, research methods, partners, legal docs, NDA for financial information, etc., submit the form …See details»
Captura Biopharma - LinkedIn
Captura Biopharma | 188 followers on LinkedIn. Captura Biopharma: Our Solution is THE Solution! | We are a group of Pharmaceutical Industry Executives, Military Vets, and Civic …See details»
Captura Biopharma - Products, Competitors, Financials, Employees ...
Captura Biopharma is a biotechnology company developing an oral solution that can immediately be administered to eliminate harmful radioactive material from the body. Use the CB Insights …See details»
Captura Biopharma - Overview, News & Similar companies
Www.capturabiopharma.com. Revenue <$5 Million. Industry Drug Manufacturing & Research Pharmaceuticals Healthcare . Recent News & Media. OceanTech Acquisitions I Corp. …See details»
Captura Biopharma | VentureRadar
Similar Companies: Sun BioPharma USA Privately Held Sun BioPharma is developing small-molecule pharmaceuticals consisting of novel polyamine analogues and metal chelators, and …See details»
Background - Captura Biopharma
Captura Biopharma’s proposed product, C2E2, is a diethyl ester of DTPA, which has been shown to be orally bioavailable and to chelate the transuranic radionuclide americium (241Am) in …See details»
Project Status - Captura Biopharma
IND-enabling tasks have been completed for C2E2, Capture’s lead development candidate, including pre-formulation characterization of the drug molecule, extensive safety-toxicology …See details»
The Solution - Captura Biopharma
Ca-DTPA (trisodium calcium diethylenetriaminepentaacetate) and Zn-DTPA (trisodium zinc diethylenetriaminepentaacetate) have been used extensively for over forty years as …See details»